Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for HCV Genotype 1-infected Patients

Clinical trial NCT00495131 · COMPLETED

Trial details

NCT number: NCT00495131
Sponsor: National Taiwan University Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2006-06-01
Primary completion: 2008-06-01
Enrollment: 308

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.